Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance

References

• Newton H, Edwards J, Mitchell L, Percival SL. Role of slough and biofilm in delaying healing in chronic wounds. Br J Nurs. 2017;26(Sup20a):S4–S11. doi:10.12968/bjon.2017.26.Sup20a.S4
   Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108. doi:10.1038/nrmicro82115040259
   PubMed Web of Science ®Google Scholar
• James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37–44. doi:10.1111/j.1524-475X.2007.00321.x18086294
   PubMed Web of Science ®Google Scholar
• Malone M, Goeres DM, Gosbell I, Vickery K, Jensen S, Stoodley P. Approaches to biofilm-associated infections: the need for standardized and relevant biofilm methods for clinical applications. Expert Rev Anti Infect Ther. 2017;15(2):147–156. doi:10.1080/14787210.2017.126225727858472
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034–1043. doi:10.1111/j.1462-5822.2009.01323.x19374653
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Moser C. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect. 2015;21(Suppl 1):S1–S25. doi:10.1016/j.cmi.2014.10.02425596784
   PubMed Web of Science ®Google Scholar
• Heng YK, Tan KT, Sen P, et al. Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance. Int J Dermatol. 2013;52:876–881. doi:10.1111/j.1365-4632.2012.05747.x23432159
   PubMed Web of Science ®Google Scholar
• Bortolin M, Bidossi A, De Vecchi E, Avveniente M, Drago L. In vitro antimicrobial activity of chlorquinaldol against microorganisms responsible for skin and soft tissue infections: comparative evaluation with gentamicin and fusidic acid. Front Microbiol. 2017;8(8):1039. doi:10.3389/fmicb.2017.0103928642751
   PubMed Web of Science ®Google Scholar
• Maeder E, Schindléry C, Macarol V, Schoenenberger PM. A comparative multicenter trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses. J Int Med Res. 1983;11(Suppl 1):48–52.6339293
   PubMed Web of Science ®Google Scholar
• Hoppe G. Diflucortolone valerate. Asian experience. Drugs. 1988;36(Suppl 5):24–33. doi:10.2165/00003495-198800365-000063254827
   PubMed Web of Science ®Google Scholar
• Corrihons I, Dutilh B, Bébéar C. In vitro activity of an antiseptic, chlorquinaldol, against Neisseria gonorrhoeae and Chlamydia trachomatis. Pathol Biol. 1991;39(2):136–139.1901985
   PubMedGoogle Scholar
• Prachayasittikul V, Prachayasittikul S, Ruchirawat S, Prachayasittikul V. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Devel Ther. 2013;7:1157–1178. doi:10.2147/DDDT.S49763
   PubMed Web of Science ®Google Scholar
• Littman ML. Antimycotic effect of chlorquinaldol. Trans N Y Acad Sci. 1955;18:161–174.13291469
   PubMedGoogle Scholar
• Mann PH, Fratta I, Sigg EB. Susceptibility testing of 200 strains of Staphylococcus aureus to chlorquinaldol. Antibiot Chemother. 1960;10:771–772.
   Google Scholar
• Clinical and Laboratory Standards Institute guidelines (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. CLSI. 2015; 10th ed.
   Google Scholar
• Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22:996–1006.3905855
   PubMed Web of Science ®Google Scholar
• Meyer JM, Abdallah MA. The fluorescent pigment of pseudomonas fluorescens: biosynthesis, purification and physicochemical properties. Microbiology. 1999;107:319–328.
   Google Scholar
• Reszka KJ, O’Malley Y, McCormick ML, Denning GM, Britigan BE. Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide. Free Radic Biol Med. 2004;36(11):1448–1459. doi:10.1016/j.freeradbiomed.2004.03.01115135182
   PubMed Web of Science ®Google Scholar
• Abu EA, Su S, Sallans L, et al. Cyclic voltammetric, fluorescence and biological analysis of purified aeruginosin A, a secreted red pigment of Pseudomonas aeruginosa PAO1. Microbiology. 2013;159(Pt 8):1736–1747. doi:10.1099/mic.0.065235-023782801
   PubMed Web of Science ®Google Scholar
• Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol. 2007;33(3):167–177. doi:10.1007/s12016-007-0044-518163223
   PubMed Web of Science ®Google Scholar
• Sonesson A, Przybyszewska K, Eriksson S, et al. Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis. Sci Rep. 2017;7(1):8689. doi:10.1038/s41598-017-08046-228821865
   PubMed Web of Science ®Google Scholar
• Akiyama H, Hamada T, Huh WK, et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol. 2003;148(3):526–532.12653745
   PubMed Web of Science ®Google Scholar
• Bergen PJ, Landersdorfer CB, Lee HJ, Li J, Nation RL. ‘Old’ antibiotics for emerging multidrug-resistant bacteria. Curr Opin Infect Dis. 2012;25(6):626–633. doi:10.1097/QCO.0b013e328358afe523041772
   PubMed Web of Science ®Google Scholar
• Strukelj R, Manfredi B, Finelli F. Trattamento di dermopatie corticoidosensibili infette con l’associazione diflucortolone valerato-clorchinaldolo. Giornale Italiano Di Ricerche Cliniche E Terapeutiche. 1982;3:177–186.
   Google Scholar
• Agner T, Menné T. Sensitivity to clioquinol and chlorquinaldol in the quinoline mix. Contact Dermatitis. 1993;29(3):163. doi:10.1111/j.1600-0536.1993.tb03524.x
   Web of Science ®Google Scholar
• Meyer-Rohn J, Puschmann M. In vitro demonstration of the antibacterial and antimycotic efficacy of a preparation containing nystatin and chlorquinaldol compared with similar antimicrobial agents. Mykosen. 1980;23:320–324.7421885
   PubMedGoogle Scholar
• Niu H, Yee R, Cui P, et al. Identification of agents active against methicillin-resistant Staphylococcus aureus USA300 from a clinical compound library. Pathogens. 2017;6:3. doi:10.3390/pathogens6030044
   Web of Science ®Google Scholar
• Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol. 1999;65(8):3710–3713.10427070
   PubMed Web of Science ®Google Scholar
• Molin S, Tolker-Nielsen T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol. 2003;14(3):255–261.12849777
   PubMed Web of Science ®Google Scholar
• Madsen JS, Burmølle M, Hansen LH, Sørensen SJ. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol. 2012;65(2):183–195. doi:10.1111/j.1574-695X.2012.00960.x22444301
   PubMedGoogle Scholar
• Savage VJ, Chopra I, O’Neill AJ. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother. 2013;57(4):1968–1970. doi:10.1128/AAC.02008-1223357771
   PubMed Web of Science ®Google Scholar
• Driffield K, Miller K, Bostock JM, O’Neill AJ, Chopra I. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother. 2008;61(5):1053–1056. doi:10.1093/jac/dkn04418256114
   PubMed Web of Science ®Google Scholar
• Boles BR, Singh PK. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci USA. 2008;105(34):12503–12508. doi:10.1073/pnas.080149910518719125
   PubMed Web of Science ®Google Scholar
• Williamson DA, Monecke S, Heffernan H, et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Clin Infect Dis. 2014;59:1451–1454. doi:10.1093/cid/ciu65825139961
   PubMed Web of Science ®Google Scholar
• McCarthy H, Rudkin JK, Black NS, Gallagher L, O’Neill E, O’Gara JP. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol. 2015;28(5):1.
   Google Scholar
• O’Neill E, Pozzi C, Houston P, et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol. 2007;45(5):1379–1388. doi:10.1128/JCM.02280-0617329452
   PubMed Web of Science ®Google Scholar
• Houston P, Rowe SE, Pozzi C, Waters EM, O’Gara JP. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun. 2011;79(3):1153–1165. doi:10.1128/IAI.00364-1021189325
   PubMed Web of Science ®Google Scholar
• Costerton JW. Introduction to biofilm. Int J Antimicrob Agents. 1999;11(3–4):217–21; discussion 237–9.
   Web of Science ®Google Scholar
• Visca P, Imperi F, Lamont IL. Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol. 2007;15(1):22–30. doi:10.1016/j.tim.2006.11.00417118662
   PubMed Web of Science ®Google Scholar
• Dietrich LE, Price-Whelan A, Petersen A, Whiteley M, Newman DK. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol Microbiol. 2006;61(5):1308–1321. doi:10.1111/j.1365-2958.2006.05306.x16879411
   PubMed Web of Science ®Google Scholar
• Das T, Kutty SK, Tavallaie R, et al. Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci Rep. 2015;11(5):8398. doi:10.1038/srep08398
   Web of Science ®Google Scholar
• Fraser RS, Creanor J. The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin. Biochem J. 1975;147:401–410. doi:10.1042/bj1470401810137
   PubMed Web of Science ®Google Scholar
• Short BR, Vargas MA, Thomas JC, O’Hanlon S, Enright MC. In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 2006;57(1):104–109. doi:10.1093/jac/dki42816319182
   PubMed Web of Science ®Google Scholar
• Culbertson JE, Toney MD. Expression and characterization of PhzE from P. aeruginosa PAO1: aminodeoxyisochorismate synthase involved in pyocyanin and phenazine-1-carboxylate production. Biochim Biophys Acta. 2013;1834(1):240–246. doi:10.1016/j.bbapap.2012.10.01023099261
   PubMed Web of Science ®Google Scholar
• Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia. 2012;16(4):303–307.23935307
   PubMed Web of Science ®Google Scholar
• Algburi A, Comito N, Kashtanov D, Dicks LM, Chikindas ML. Control of biofilm formation: antibiotics and beyond. Appl Environ Microbiol. 2017;83(3):e02508–e02516. doi:10.1128/AEM.02508-1627864170
   PubMed Web of Science ®Google Scholar
• Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 2006;72(3):2064–2069. doi:10.1128/AEM.72.3.2064-2069.200616517655
   PubMed Web of Science ®Google Scholar
• Kessler HJ. Local antiseptics versus antibiotics in topical therapy – the emergence of microbial resistance. Mykosen. 1980;23(6):285–289.7421882
   PubMedGoogle Scholar